Effect of lymphokines on natural killer cytotoxicity in patients with high risk of developing the acquired immune deficiency syndrome.

[1]  P. Barr,et al.  Modulation of human natural killer cell activity by recombinant human interleukin 2. , 1985, Cellular immunology.

[2]  A. Fauci,et al.  Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. , 1985, Journal of immunology.

[3]  H. Shepard,et al.  Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2. , 1984, Journal of immunology.

[4]  M. Grieco,et al.  Interleukin 2 augmentation of natural killer cell activity in homosexual men with acquired immune deficiency syndrome , 1984, Infection and immunity.

[5]  V. Zakuth,et al.  Interleukin-2 production and response to exogenous interleukin-2 in a patient with the acquired immune deficiency syndrome (AIDS). , 1984, Clinical and experimental immunology.

[6]  S. Baron,et al.  Interleukin 2 enhances natural killing of normal lymphocytes. , 1984, Cellular immunology.

[7]  E. Engleman,et al.  Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. , 1983, Journal of immunology.

[8]  M. Lederman,et al.  Impaired cell-mediated immunity in patients with classic hemophilia. , 1983, The New England journal of medicine.

[9]  J. Nielsen,et al.  Severe acquired immunodeficiency in European homosexual men. , 1982, British medical journal.

[10]  D. Knowles,et al.  OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer. , 1982, Journal of immunology.

[11]  J. Ortaldo,et al.  Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity , 1979, Nature.